FSK
Earnings in 5 days · May 6, 2026 · After close
Signal
Bullish Setup2
Price
1
Move+5.34%Strong session
Volume
1
Volume0.8× avgNormal activity
Technical
1
RSIRSI 58Momentum positive
PRICE
Prev Close
10.68
Open
10.62
Day Range10.62 – 11.27
10.62
11.27
52W Range9.72 – 22.68
9.72
22.68
12% of range
VOLUME & SIZE
Avg Volume
4.2M
FUNDAMENTALS
P/E Ratio
281.3x
Premium valuation
EPS (TTM)
Div Yield
0.13%
Beta
0.72
Low vol
Performance
1D
+5.34%
5D
+5.53%
1M
+13.07%
3M
-18.42%
6M
-25.30%
YTD
-24.04%
1Y
-43.44%
Best: 1M (+13.07%)Worst: 1Y (-43.44%)
Quick Read
TrendInsufficient MA data
Momentum
NEUTRAL
rev -34% · 42% gross margin
Valuation
EXPENSIVE
P/E 281x vs ~20x sector
Health
MODERATE
CR 0.0 (low) · FCF $0.00/sh
Neutral
Key MetricsTTM
Market Cap$3.15B
Revenue TTM$736.00M
Net Income TTM$11.00M
Free Cash Flow$1.00M
Gross Margin41.6%
Net Margin1.5%
Operating Margin19.3%
Return on Equity0.2%
Return on Assets0.1%
Debt / Equity1.31
Current Ratio0.00
EPS TTM$0.04
Alpha SignalsFull Analysis →
What Moves This Stock

Net investment income (NII) per share and dividend coverage ratio - ability to sustain quarterly distributions

Non-accrual rate and portfolio credit quality metrics - percentage of investments on non-accrual status signals distress

Net asset value (NAV) per share changes - unrealized gains/losses from fair value markdowns drive book value

Credit spread movements in leveraged loan markets - tighter spreads compress new origination yields

Macro Sensitivity
Economic Cycle

high - Middle-market borrowers are highly sensitive to economic downturns, with elevated default risk during recessions. Portfolio company EBITDA deterioration leads to covenant breaches, payment defaults, and equity value impairments. The -98% net income decline suggests significant recent credit stress or portfolio markdowns. Revenue growth remains positive (5.5%) due to higher base rates on floating-rate loans, but credit losses have overwhelmed interest income gains.

Interest Rates

Complex dual exposure: (1) Rising short-term rates (SOFR) increase interest income on floating-rate loan portfolio (80-90% of investments typically float), providing near-term NII tailwind. (2) However, rising rates also increase FSK's own borrowing costs on credit facilities and unsecured debt, compressing net interest margin. (3) Higher rates reduce middle-market borrower cash flows and increase refinancing risk, elevating default probability. (4) Rising risk-free rates make BDC dividend yields less attractive relative to Treasuries, compressing valuation multiples. The current environment (March 2026) with sustained elevated rates has likely pressured both credit quality and valuation.

Key Risks

Regulatory constraints under Investment Company Act of 1940 limit leverage to 2.0x debt-to-equity and require 90% income distribution, restricting capital retention for growth or loss absorption

Secular shift toward private credit funds and direct lending platforms reduces BDC competitive positioning, as institutional investors increasingly bypass public BDCs for higher-return private vehicles

Middle-market lending market saturation with aggressive competition from banks, private credit funds, and other BDCs compressing origination spreads and loosening underwriting standards

Investor Profile

dividend/value - BDCs traditionally attract income-focused investors seeking high yields (FSK likely yields 12-15% at current distressed prices). The 0.5x P/B ratio appeals to deep value investors betting on credit cycle recovery and NAV stabilization. However, the -53% annual return and -98% earnings decline have likely driven significant retail and income investor capitulation. Current holders are likely distressed debt specialists or contrarian value investors with high risk tolerance.

Watch on Earnings
BAMLH0A0HYM2 (High Yield Credit Spreads) - widening spreads signal credit stress and mark-to-market losses on portfolioFEDFUNDS and SOFR base rates - directly impact both asset yields and liability costsS&P/LCD Leveraged Loan Index default rates and recovery rates for middle-market creditsNAV per share trajectory and quarterly fair value adjustments by portfolio company
Health Radar
1 watch5 concern
11/100
Liquidity
0.00Concern
Leverage
1.31Watch
Coverage
0.3xConcern
ROE
0.2%Concern
ROIC
0.4%Concern
Cash
$181MConcern
ANALYST COVERAGE10 analysts
HOLD
+46.7%upside to target
L $15.00
Med $16.50consensus
H $18.00
Buy
220%
Hold
880%
2 Buy (20%)8 Hold (80%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
6/10
Technicals
RSI RangeRSI 58 — Bullish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 0.00 — liquidity risk
Upcoming Events
EEarnings ReportMay 2, 2026
Tomorrow
DEx-Dividend DateJul 30, 2026
In 90 days
PDividend PaymentOct 22, 2026
In 174 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

RallyDeath Cross · 50D trails 200D by 27.0%

+4.5% vs SMA 50 · -23.7% vs SMA 200

Momentum

RSI58.2
Positive momentum, not extended
MACD+0.03
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$22.68+101.6%
EMA 200
$14.68+30.5%
Current
$11.25
EMA 50
$11.15-0.9%
52W Low
$9.72-13.6%
52-Week RangeNear 52-week low
$9.7212th %ile$22.68
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:7
Dist days:1
Edge:+6 acc
Volume Context
Avg Vol (50D)1.2M
Recent Vol (5D)
957K-17%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 9 analysts
Analyst revisions:Revenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$1.8B
$1.7B$1.9B
$2.39
±6%
High7
FY2024
$1.7B
$1.7B$1.7B
-4.2%$2.90+21.3%
±2%
High8
FY2025
$1.5B
$1.5B$1.6B
-11.5%$2.36-18.6%
±1%
High9
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryFSK
Last 8Q
-26.3%avg beat
Beat 3 of 8 quartersMissed 4 Estimates falling
+3%
Q2'24
+6%
Q3'24
-19%
Q4'24
-1%
Q1'25
+2%
Q2'25
-195%
Q3'25
Q4'25
-5%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
Wells FargoEqual-Weight → Overweight
May 29
UPGRADE
Insider Activity
SEC Filings →
6 Buys/0 SellsNet Buying
Kropp James HDir
$19K
Feb 27
BUY
Pietrzak DanielDir
$56K
Feb 27
BUY
Hopkins Jerel ADir
$7K
Dec 5
BUY
Forman Michael C.CEO
$155K
Nov 11
BUY
Pietrzak DanielDir
$152K
Nov 7
BUY
Hopkins Jerel ADir
$6K
Sep 3
BUY
Financials
Dividends22.93% yield
3 yrs of payments
Annual Yield22.93%
Quarterly Div.$0.4800
Est. Annual / Share$1.92
FrequencyQuarterly
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
Beach Point Capital Management LP
3.1M
2
COMMONWEALTH EQUITY SERVICES, LLC
2.6M
3
Cambridge Investment Research Advisors, Inc.
1.7M
4
Muzinich & Co., Inc.
856K
5
Sumitomo Mitsui Trust Holdings, Inc.
789K
6
Kestra Advisory Services, LLC
781K
7
U.S. Capital Wealth Advisors, LLC
607K
8
Andina Capital Management, LLC
563K
News & Activity

FSK News

20 articles · 4h ago

About

sam investment corp is a financial services company located in 4550 w oakey blvd 104a, las vegas, nevada, united states.

CEO
Michael Forman
Country
United States
Daniel Ryan PietrzakPresident, Chief Investment Officer & Director
Michael John KellyPresident & Chief Investment Officer of FS Investments
Peers(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
FSK
$11.25+5.34%$3.2B286.4+549.5%93.9%1500
$396.06+0.57%$2.1T28.7+3296.8%4510.0%1500
$91.86+2.89%$318.3B14.0+318.8%1510.7%1500
$131.91+1.13%$306.2B22.6+586.3%1305.9%1500
$187.37+1.17%$290.5B28.1+862.9%1745.9%1500
$147.85+3.44%$282.1B21.0+597.3%2564.4%1500
$90.67+1.98%$256.7B14.5-591.0%668.4%1500
Sector avg+2.36%59.3+803.0%1771.3%1500